The Nano BioDiscovery™ Division of NanoInk®, Inc. announced today the release of a new automated platform for the analysis of its protein NanoArray assays. NanoInk’s NanoArray Assay System™ enables detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and […]
OCKVILLE, Md. — BioReliance, a leading provider of global biopharmaceutical testing services, announced today that it has agreed to be acquired by Sigma-Aldrich Corporation (NASDAQ: SIAL). Avista Capital Partners, the majority owner of BioReliance Holdings, Inc., agreed to sell the company for $350 million in cash. The acquisition is subject to customary closing conditions, including […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced it has named Marc Stapley, former Senior Vice President, Finance, at Pfizer and Americas Chief Financial Officer at Alcatel-Lucent, to the position of Senior Vice President and Chief Financial Officer. Stapley will report to President and Chief Executive Officer Jay Flatley and will oversee Illumina’s finance, accounting, facilities […]
Illumina, Inc. (NASDAQ: ILMN) today announced it has appointed Laura Lauman as Vice President of Marketing. In this executive management position, Lauman will lead Illumina’s global marketing efforts. “Lauman has a distinguished track record of success in building and driving growth in global, complex businesses and has significant general management experience in sales, marketing, R&D […]
Basel, Roche today announced that Sophie Kornowski-Bonnet, currently General Manager of Roche Pharma in France, has been appointed Head of Roche Partnering. Sophie Kornowski-Bonnet will assume her new role on February 1, 2012, and concurrently will join Roche’s enlarged Corporate Executive Committee, reporting to Severin Schwan, CEO of the Roche Group. She will relocate to […]
Gaithersburg, Maryland – Ocimum Biosolutions, Inc. (d/b/a Gene Logic) today announced that it has retained Burrill & Company, Inc. as its strategic advisor. Burrill will assist the company in evaluating strategic alternatives related to Gene Logic and its assets, which could include a sale of its US-based company, operations or its assets. Burrill is actively […]
SUNNYVALE, Calif.–Arrayit Corporation has approved the spin-off of its majority owned subsidiary, Arrayit Diagnostics, Inc. Arrayit Corporation will distribute to its existing shareholders its 78.18% interest in Arrayit Diagnostics as a stock dividend. The stock dividend distribution date and further details are expected to be announced early in the first quarter of 2012. Since July […]
SELANGOR, Malaysia, Agilent Technologies Inc. (NYSE: A) and Monash University Sunway campus today announced a collaboration to promote talent and skills development for genomics research in Malaysia. This partnership, the first of its kind for Agilent with a university in Malaysia, will help Malaysia assert itself as a leading center for life sciences research and […]
AMSTERDAM, Elsevier, a world-leading provider of scientific, technical, and medical information products and services, announced today the acquisition of the business assets of Ariadne Genomics, a provider of pathway analysis tools and semantic technologies for life science researchers. Ariadne will be integrated with Elsevier’s Corporate Markets division. “Ariadne Genomics’ pathway analysis tools and semantic technologies […]
SANTA CLARA, Calif. & RESEARCH TRIANGLE PARK, N.C., Agilent Technologies Inc. (NYSE:A) and the Agilent Technologies Foundation today announced that Russell S. Thomas, Ph.D., of the Hamner Institutes for Health Sciences has been selected for an Agilent Thought Leader Award to support his work developing methods to predict drug-induced liver injury. The award includes funding […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
